0001846802-21-000001.txt : 20210224 0001846802-21-000001.hdr.sgml : 20210224 20210224154214 ACCESSION NUMBER: 0001846802-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210224 DATE AS OF CHANGE: 20210224 EFFECTIVENESS DATE: 20210224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ribogenics, Inc. CENTRAL INDEX KEY: 0001846802 IRS NUMBER: 824855128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390403 FILM NUMBER: 21672386 BUSINESS ADDRESS: STREET 1: C/O SGRV P.C. 1635 MARKET STREET STREET 2: 7TH FL CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 9194127411 MAIL ADDRESS: STREET 1: C/O SGRV P.C. 1635 MARKET STREET STREET 2: 7TH FL CITY: PHILADELPHIA STATE: PA ZIP: 19103 D 1 primary_doc.xml X0708 D LIVE 0001846802 Ribogenics, Inc. C/O SGRV P.C. 1635 MARKET STREET 7TH FL PHILADELPHIA PA PENNSYLVANIA 19103 9194127411 DELAWARE None None Corporation true 2018 Yves Ribeill c/o SGRV P.C. 1635 Market Street, 7th Floor Philadelphia PA PENNSYLVANIA 19103 Executive Officer Laurent Arthaud c/o SGRV P.C. 1635 Market Street, 7th Floor Philadelphia PA PENNSYLVANIA 19103 Director Serge Braun c/o SGRV P.C. 1635 Market Street, 7th Floor Philadelphia PA PENNSYLVANIA 19103 Director Wei Zhang c/o SGRV P.C. 1635 Market Street, 7th Floor Philadelphia PA PENNSYLVANIA 19103 Director Biotechnology No Revenues 06b false 2021-02-10 false true false 0 8000000 6025000 1975000 The Total Amount Sold includes amounts to be purchased upon the completion of certain milestone events. false 3 0 0 0 false Ribogenics, Inc. Yves Ribeill Yves Ribeill CEO & President 2021-02-24